THC

Tenet Healthcare Corp. 10-Q Summary (Period Ended Sept 30, 2006)

Business Context and Reporting Period

Tenet Healthcare Corporation is an investor-owned health care services company operating general hospitals and related facilities. As of September 30, 2006, the company operated 66 general hospitals with 17,016 licensed beds across 12 states. This report covers the quarterly and nine-month periods ended September 30, 2006. The company is in a turnaround phase, focusing on divesting underperforming assets, resolving legacy litigation, and improving operational efficiency.

Key Financial Metrics

Profitability: The company reported a net loss of $417 million for the nine months ended September 30, 2006, compared to a net loss of $438 million in the prior year period. Operating loss was $507 million, driven primarily by litigation costs. Loss per diluted share from continuing operations was $1.02.

Liquidity: Unrestricted cash and cash equivalents totaled $809 million. The company has $263 million in restricted cash collateralizing letters of credit. A new $800 million senior secured revolving credit facility was committed in September 2006.

Material Changes vs. Prior Period

• Revenue: Net operating revenues increased slightly by $31 million (0.5%) year-over-year. This was driven by improved managed care pricing and favorable Medicaid disproportionate-share revenue, partially offset by volume declines and increased discounts under the "Compact" program for uninsured patients.
• Operating Expenses: Operating expenses increased significantly due to a $751 million charge for "Costs of litigation and investigations" in 2006, compared to $47 million in 2005. This charge primarily reflects the June 2006 global civil settlement with the U.S. Department of Justice ($470 million) and other legal settlements.
• Impairment and Restructuring: Net impairment and restructuring charges were $57 million in 2006 (including a $35 million goodwill impairment) compared to $14 million in 2005.
• Discontinued Operations: The company recorded a net gain of $59 million from discontinued operations in 2006, compared to a loss of $312 million in 2005. This improvement was largely due to $186 million in hurricane insurance recoveries and the sale of assets.
• Cash Flow: Operating cash flow swung from a positive $685 million in 2005 to a negative $441 million in 2006. The primary driver was the $610 million increase in payments for legal settlements and related costs, offset by a $537 million income tax refund received in 2005 that did not recur.

Guidance, Outlook, Risks, and Unusual Items

Management Commentary: Management emphasizes a turnaround strategy involving the divestiture of 10 hospitals (with several sales completed or agreed upon in late 2006) to focus on core profitable operations. The company has resolved the majority of legacy litigation issues through the June 2006 global settlement.

Unusual Items:

• Global Civil Settlement: A $470 million payment (plus interest) to the U.S. DOJ and other agencies was made in June 2006, significantly impacting operating income and cash flow.
• IRS Revenue Agent's Report (RAR): In October 2006, the IRS issued a report proposing a tax deficiency of $207 million plus interest. Approximately $85 million of the undisputed portion is expected to be paid by year-end. The company plans to appeal the remaining disputed $82 million.
• Hurricane Katrina: The company received $340 million in insurance settlements related to Hurricane Katrina, recorded largely in discontinued operations.

Risks and Contingencies:

• Volume Decline: Patient days and admissions continue to decline due to competition, physician attrition, and negative publicity from past investigations.
• Bad Debt: High levels of uninsured patients and managed care payment delays remain a challenge, though the "Compact" program aims to reduce bad debt provisions.
• Regulatory: The company entered a five-year Corporate Integrity Agreement (CIA) with the HHS Office of Inspector General, requiring enhanced compliance monitoring.
• Legal: Pending matters include a qui tam action in Texas, a lawsuit by the University of Southern California regarding a hospital lease, and ongoing wage and hour class actions in California.

Investor Verification Checklist

• IRS Tax Dispute: Verify the status of the $207 million proposed tax deficiency and the company's ability to fund the $85 million undisputed payment without further liquidity strain.
• Divestiture Progress: Confirm the closing of the remaining hospital sales (e.g., Alvarado, Hollywood, Parkway) and the actual proceeds received versus the estimated $36.5 million to $35 million range.
• Volume Trends: Monitor patient admission and day statistics to determine if the volume decline is stabilizing or accelerating despite cost-cutting measures.
• Legal Reserves: Review the adequacy of reserves for the pending qui tam actions and the USC University Hospital lease dispute.
• Debt Covenants: Assess compliance with debt covenants, particularly given the new $800 million secured credit facility and the impact of the global settlement on leverage ratios.